Related Experiment Videos
Albendazole treatment in human taeniasis
1Dirección de Investigación Científica, Universidad Nacional Autónoma de Honduras.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|September 1, 1991
Summary
Albendazole effectively treated human taeniasis (tapeworm infections) in Honduras. Studies showed it was well-tolerated and highly effective, with all patients remaining infection-free after treatment.
Area of Science:
- Infectious Diseases
- Parasitology
- Tropical Medicine
Background:
- Taeniasis, caused by tapeworm infections, is a significant public health concern in rural communities.
- Accurate diagnosis of taeniasis is challenging, impacting treatment efficacy assessment.
Purpose of the Study:
- To evaluate the efficacy and tolerability of albendazole for treating human taeniasis.
- To compare diagnostic methods for detecting tapeworm infections.
Main Methods:
- A clinical trial involving 56 individuals with confirmed taeniasis in Honduras.
- Albendazole administered at 400 mg daily for 3 days.
- Diagnostic methods included Kato cellophane thick smear, perianal swab, and clinical history.
Main Results:
- Albendazole treatment resulted in 100% negative stool examinations at 60 and 90 days post-treatment.
- Tapeworm segments (Taenia saginata and Taenia solium) were recovered from 37.5% of patients, indicating successful expulsion.
- Kato and perianal swab combination showed 88% diagnostic reliability, superior to clinical history.
Conclusions:
- Albendazole is a well-tolerated and highly effective drug for treating Taenia spp. infections.
- Reliable diagnostic methods are crucial for confirming treatment success in taeniasis.
- Further confirmation studies are recommended due to diagnostic challenges.